Mark Jones

Has grant

Professor of Respiratory Medicine

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Jones is a Professor of Respiratory Medicine at the University of Southampton, UK. His research primarily focuses on lung diseases, including lung fibrosis and the effects of COVID-19 on respiratory health. Recent publications have explored topics such as the mechanistic subtypes of long COVID, biomarkers related to COVID-19 severity, and the efficacy of individualized exercise training for idiopathic pulmonary fibrosis.

Recent Grants

Grant: Close

Mis-programming of mesenchymal progenitor cells in human lung fibrosis.

Open Date: 2022-09-30

Close Date: 2026-09-29

Grant: Close

The UK Interstitial Lung Disease Long-COVID19 study (UKILD-Long COVID): understanding the burden of Interstitial Lung Disease in Long COVID.

Open Date: 2021-02-17

Close Date: 2022-08-15

Grant: Close

PHOSP-COVID Post-hospitalisation COVID-19 study: a national consortium to understand and improve long-term health outcomes

Open Date: 2020-07-29

Close Date: 2022-08-28

Grant: Close

Dissecting fibrotic lung sarcoidosis to enable effective targeted treatment

Open Date: 2020-01-06

Close Date: 2022-01-05

Grant: Close

Development of micro-computed tomography (ìCT) for enhanced diagnosis and prognosis in interstitial lung diseases (ILD)

Open Date: 2016-03-01

Close Date: 2017-11-20

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (76)

Bronwen Connolly

The Queen's University Belfast

UNITED KINGDOM

Mark Jones

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.

Accelarated immune ageing is associated with COVID-19 disease severity.

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary Fibrosis

Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.

Spatially resolved deconvolution of the fibrotic niche in lung fibrosis

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)

Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis.

Fatality Rate and Survival Time of Laboratory-Confirmed COVID-19 for Patients in England During the First Wave of SARS-CoV-2 Infection: A Modelling Study.

Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment

Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema

Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets

Collaborators (76)

Bronwen Connolly

Jonathan Heeney

Davies Adeloye

Ahilanandan Dushianthan

Daniel Peckham

Julian Griffin

Michael Marks

Kay Por Yip

John R. Petrie

Neil Hanley

Jacob George

Andres Felipe Vallejo

Hamish McAuley

David Barber

Mark Halling-Brown

Giles Dixon

Cherie Armour

Pilar Rivera-Ortega

Luke Daines

David R Baldwin

Anthony Rostron

Joanna Simpson

Julie Whitney

Elizabeth Sage

Jon Hazeldine

Huzaifa Adamali

Gerry McCann

Charlotte Bolton

Jodie Chalmers

Timothy Wallis

Michael Gibbons

Jim Wild

Salman Siddiqui

Karen Piper Hanley

Lucy Elizabeth Mary Finnigan

Tao Dong

Rachel Upthegrove

Vicky Kamwa

Laura Fabbri

Lauren Robinson

Clark Russell

Sandy Jack

Scott Denham

Manish Patel

Catherine Atkin

Neil Greening

Michael Crooks

Michelle Holland

Keith M. Channon

Stephen P. McAdoo

John Kenneth Baillie

Robert Francis

Mark Spears